Winkler T, Trampuz A, Hardt S, Janz V, Kleber C, Perka C
Abteilung für Septische Chirurgie und Protheseninfektion, Klinik für Orthopädie, Centrum für Muskuloskeletale Chirurgie, Charité-Universitätsmedizin Berlin, Augustenburgerplatz 1, 13353, Berlin, Deutschland,
Orthopade. 2014 Jan;43(1):70-8. doi: 10.1007/s00132-013-2132-y.
Periprosthetic infections (PPI) represent one of the most complex complications in arthroplasty concerning both, diagnosis and therapy. The incidence of PPI of the hip is approximately 1 % after primary procedures and 4 % after revision surgery. About two thirds of PPIs occur via intraoperative contamination and the remaining PPIs are acquired by hematogenous seeding.
This article presents an overview of up to date evidence-based diagnostics and therapy of PPI of the hip with the establishment of a clear algorithm.
A selective literature search was carried out with the inclusion of own work.
A PPI must be actively excluded in cases of a painful prosthesis or signs of loosening within the first years after implantation. Measurement of C-reactive protein (CRP) can be normal especially in cases of chronic (low grade) PPI and cannot be used as an exclusion criterion. The standard diagnostic procedure includes preoperative joint aspiration with culture and leukocyte counts as well as culture and histology of periprosthetic tissue. Imaging techniques, such as magnetic resonance imaging (MRI) and scintigraphy are of inferior significance. Newer methods, such as sonication of removed implants have revolutionized the diagnostics and several cases which had previously been considered aseptic loosening failures have now been reclassified as PPI. Essential parameters for the treatment algorithm are maturity of the biofilm, stability of the prosthesis, the causative organism and the state of the soft tissue. Retention of the prosthesis can only be considered when the biofilm is still immature (acute PPI). In chronic (low grade) PPI eradication of the infection can only be achieved by exchanging the prosthesis. This has to be performed either as a one-stage procedure or as a two-stage exchange with a short (2-4 weeks) or a long (> 6 weeks) interval. Biofilm active antibiotics play an essential role in the treatment of PPI and have to be used as targeted therapy.
Successful therapy and diagnostics of PPI require following an exact algorithm. The interdisciplinary cooperation between specialists for infectious diseases and microbiologists represents a decisive factor.
假体周围感染(PPI)是关节置换术中最复杂的并发症之一,涉及诊断和治疗两个方面。初次手术时髋关节PPI的发生率约为1%,翻修手术后为4%。约三分之二的PPI通过术中污染发生,其余的PPI则通过血行播散获得。
本文通过建立清晰的算法,对髋关节PPI的最新循证诊断和治疗进行综述。
进行选择性文献检索并纳入自身研究成果。
在植入后的头几年内,若假体疼痛或出现松动迹象,必须积极排除PPI。C反应蛋白(CRP)的测量结果可能正常,尤其是在慢性(低度)PPI的情况下,不能将其用作排除标准。标准诊断程序包括术前关节穿刺并进行培养和白细胞计数,以及假体周围组织的培养和组织学检查。成像技术,如磁共振成像(MRI)和闪烁扫描术的意义较小。较新的方法,如对取出的植入物进行超声处理,彻底改变了诊断方式,一些先前被认为是无菌性松动失败的病例现在已被重新归类为PPI。治疗算法的基本参数是生物膜的成熟度、假体的稳定性、致病微生物和软组织的状态。只有当生物膜仍未成熟(急性PPI)时,才可以考虑保留假体。在慢性(低度)PPI中,只有通过更换假体才能根除感染。这必须作为一期手术或分两期进行更换,间隔时间短(2 - 4周)或长(> 6周)。生物膜活性抗生素在PPI的治疗中起着至关重要的作用,必须用作靶向治疗。
PPI的成功治疗和诊断需要遵循精确的算法。传染病专家和微生物学家之间的跨学科合作是一个决定性因素。